Variable role of patent ductus arteriosus

被引：4

作者：

Shepherd, Jennifer ^{[1
]}

Hsu, Kai-Hsiang ^{[1
,2
,3
]}

Noori, Shahab ^{[1
]}

机构：

[1] Univ Southern Calif, Childrens Hosp Los Angeles, Keck Sch Med, Fetal & Neonatal Inst,Div Neonatol,Dept Pediat, Los Angeles, CA USA

[2] Chang Gung Mem Hosp, Dept Pediat, Div Neonatol, Linkou Branch, Taoyuan, Taiwan

[3] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan

来源：

SEMINARS IN FETAL & NEONATAL MEDICINE | 2018年 / 23卷 / 04期

关键词：

Congenital diaphragmatic hernia; Congenital heart defect; Prostaglandin; Pulmonary hypertension; Patent ductus arteriosus; PERSISTENT PULMONARY-HYPERTENSION; CONGENITAL DIAPHRAGMATIC-HERNIA; HEART-DISEASE; MANAGEMENT; PROSTAGLANDIN-E1; PREVALENCE;

D O I：

10.1016/j.siny.2018.05.002

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Although patent ductus arteriosus is essential in fetal life, interventions to close or minimize the adverse hemodynamic effects associated with the left-to-right shunt are often needed after birth, especially in extremely premature infants. However, there are clinical conditions where maintaining patency of the ductus is essential for survival. In this article we discuss use of prostaglandin E-1 in the management of congenital heart defects, pulmonary hypertension and left ventricular failure in early neonatal period.

引用

页码：273 / 277

页数：5

共 33 条

[1] Preoperative management of the neonate with critical aortic valvar stenosis [J].